Pazopanib and Statin-Induced Rhabdomyolysis

Pazopanib and Statin-Induced Rhabdomyolysis

Background: The VEGF inhibitor pazopanib is a widely used first-line therapy for the treatment of advanced renal cell carcinoma. Potential drug-drug interactions and toxicities may be underrecognized. Case Presentation: A 73-year-old woman with metastatic renal cell carcinoma on treatment with pazop...

Full description

Bibliographic Details
Main Authors: Jennifer M. Logue, Bahram Kiani, Rhonda L. Bitting
Format: Article
Language:English
Published: Karger Publishers 2017-10-01
Series:Case Reports in Oncology
Subjects:
Pazopanib
Rosuvastatin
Rhabdomyolysis
VEGF inhibitor
Statin
Hyperlipidemia
Renal cell carcinoma
Cytochrome p450
Online Access:https://www.karger.com/Article/FullText/481659

Internet

https://www.karger.com/Article/FullText/481659

Similar Items